Westat at 2022 SCDM Conference
Home » In Focus » Supporting CDISC Adoption Across the NCI Community

Supporting CDISC Adoption Across the NCI Community

Westat @ 2022 SCDM Conference.

September 12, 2022

Westat expertise in is on hand at the 24th SCDM Annual Conference, held September 11-14, 2022, in San Antonio, Texas. The conference is considered the world’s leading clinical data management (CDM) conference, providing the opportunity for CDM knowledge sharing and education.

Westat’s Ginger Riley and coauthor Neesha Desai will present : Adoption of CDISC Across the NCI Community. The National Cancer Institute’s (NCI’s) Cancer Therapy Evaluation Program (CTEP) oncology clinical trial data must be submitted to the Food and Drug Administration (FDA) in the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) format. A compliant and efficient process for FDA data submissions was needed for the NCI CTEP oncology clinical trials. Their presentation discusses how Westat supports this process.

Learn more: NCI CTEP CDISC Implementation

More News

  • Westat CLS—Showcasing CRO Services to Commercial Clients

    Westat CLS—Showcasing CRO Services to Commercial Clients

  • What Pneumonia Vaccine Prompts the Best Immunity Response in Infants Whose Mothers Have HIV?

    What Pneumonia Vaccine Prompts the Best Immunity Response in Infants Whose Mothers Have HIV?

  • First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP)

    First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP)